Company profile
Instil Bio, Inc.
NASDAQ:TILBiotechnology: Biological Products (No Diagnostic Substances)
Clinical trials (3)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05050006 | phase2 | terminated | 2021-10-07 | 2023-02-27 | Instil Bio | ITIL-168 in Advanced Melanoma |
| NCT05393635 | phase1 | withdrawn | 2022-08-01 | 2022-12-08 | Instil Bio | ITIL-168 in Advanced Solid Tumors |
| NCT05397093 | phase1 | terminated | 2022-08-24 | 2023-10-10 | Instil Bio | ITIL-306 in Advanced Solid Tumors |
FDA applications (0)
No records yet.